Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Company Update

3 Dec 2021 07:00

RNS Number : 4352U
Highbridge Tactical Credit Fund Ltd
03 December 2021
 

3 December 2021

HIGHBRIDGE TACTICAL CREDIT FUND LIMITED

(the "Company")Registration No. 44704

Registered Office:SARNIA HOUSE, LE TRUCHOT, ST PETER PORT,GUERNSEY GY1 1GR 

TELEPHONE: +44 1481 737600FACSIMILE: +44 1481 749829

Company Update

 

 

 

Distributions received from the Highbridge Tactical Credit Master Fund ("HTCMF")

On 23rd November 2021 the Company distributed the 4th of 4 quarterly distributions arising from the redemption of its initial core holding in the HTCMF.

Residual holding in HTCMF

There remains a residual holding in the HTCMF as a result of distributions being made during 2021 from Highbridge Multi Strategy Master Fund (Multi-Strategy Master Fund) (in wind down) in the form of shares allocated in HTCMF, with the most recent reinvestment occurring on 1 October 2021. This latter fund can only be redeemed over the course of a full calendar year in quarterly instalments which effectively extends the minimum wind down period for the Company's portfolio to twelve months from the last Multi-Strategy Master Fund conversion into HTCF. There has been a positive development in that regard, in response to a request from the Company, Highbridge has recently provided an ability to elect to receive any future distributions from Multi-Strategy Master Fund in the form of cash.

Residual holding in Multi-Strategy Master Fund

The Investment manager is endeavouring to monetise the final 3 holdings in Multi-Strategy Master Fund to enable cash to be distributed to all shareholders (including the Company). We are hopeful that the final holding in the Multi-Strategy Master Fund will be realised and distributed in the first half of 2022. However, there can be no certainty as to the timing of the final distribution from Multi-Strategy Master Fund

Residual holding in AllBlue Funds

As previously advised, BlueCrest (the former investment manager of the AllBlue funds- in liquidation) was ordered by the SEC in December 2020 to pay USD 170 million to harmed investors. At the beginning of November, the SEC advised of its proposal to apportion the assets of a Fair Fund in which the USD170 million will be lodged to only US Investors. The Company has availed of the opportunity to register its concerns with the SEC regarding the proposal being unfair to non-US investors such as the AllBlue Funds. The Liquidators of the AllBlue Funds have assured your board that they intend to lodge similar concerns with the SEC within the 30 days' consultation period.

Managing costs in wind down

To further reduce the fixed costs of the Company, the board have volunteered to implement an additional fee waiver in addition to the one that is currently in force and will waive 50% of their current fees with effect from 1st December 2021. The Company is likely to continue with its listing on the London Stock Exchange until mid-2022 to avoid the cost of reaching out to all investors and creditors for AML documentation.

The directors have decided that the accounting period should be extended to 30th June 2022 as this will provide the maximum permitted additional time under UK listing rules and Guernsey law for the SEC to respond on whether AllBlue investors will be entitled to a distribution from the Fair Fund and for Highbridge to liquidate the remainder of the HMSF portfolio.

 

The Company will produce an unaudited interim set of results as at 31 December 2021. Monthly estimated NAVs will continue to be produced until the Company delists from the London Stock Exchange and is handed over to a Liquidator.

NAVs from 30th Nov 2021 will include a provision for the estimated wind up costs allocated to shareholders. An appropriate portion of wind up costs will be allocated to creditors too, based on their pro rata share of the gross assets of the Company during the wind down process. 

 

For further information contact:

 

Praxis Fund Services Limited

Company Secretary

 

Tel: +44 (0) 1481 737 600

LEI: 213800397SYHLYFH5961

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFSSFMEEFSEDE
Date   Source Headline
1st Nov 20232:02 pmRNSCompany Update
27th Oct 20235:30 pmRNSHighbridge Tactical Credit Fund
18th Oct 20231:37 pmRNSCompany Update
3rd Oct 20239:36 amRNSDirector Declaration
28th Apr 20232:33 pmRNSTotal Voting Rights
17th Apr 20237:00 amRNSShares in issue
30th Mar 20235:02 pmRNSHalf-year Report
29th Mar 20232:11 pmRNSReturn of Capital
29th Mar 20232:08 pmRNSCash Distribution
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:00 amRNSDirector Declaration
16th Mar 20237:00 amRNSCompany Update and Return of Capital Information
15th Mar 20234:36 pmRNS2019 Redemption Portfolio
15th Mar 20234:30 pmRNSNet Asset Value(s)
7th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSChange of Registered Office
2nd Dec 202211:44 amRNSResult of AGM
21st Nov 20223:05 pmRNSHolding(s) in Company
9th Nov 20227:00 amRNSNotice of AGM
8th Nov 20224:00 pmRNSNet Asset Value(s)
8th Nov 20224:00 pmRNS2019 Redemption Portfolio
7th Nov 20225:00 pmRNS2019 Redemption Portfolio
7th Nov 20224:58 pmRNSNet Asset Value(s)
2nd Nov 20227:00 amRNSDistribution
31st Oct 20223:22 pmRNSAnnual Financial Report
20th Oct 202210:47 amRNSAudit Opinion
18th Oct 202211:04 amRNSNet Asset Value(s)
18th Oct 202211:03 amRNS2019 Redemption Portfolio
25th Aug 20224:50 pmRNSNet Asset Value(s)
25th Aug 20224:41 pmRNS2019 Redemption Portfolio
1st Aug 20229:51 amRNS2019 Redemption Portfolio
1st Aug 20229:45 amRNSNet Asset Value(s)
5th Jul 202211:09 amRNS2019 Redemption Portfolio
5th Jul 202211:03 amRNSNet Asset Value(s)
1st Jun 202211:22 amRNSNet Asset Value(s)
1st Jun 202211:20 amRNS2019 Redemption Portfolio
7th Apr 20228:38 amRNSNet Asset Value(s)
7th Apr 20228:24 amRNS2019 Redemption Portfolio
25th Mar 202211:22 amRNSNet Asset Value(s)
25th Mar 202211:15 amRNS2019 Redemption Portfolio
22nd Mar 202211:00 amRNSCash Exit Payment
21st Mar 20223:02 pmRNSInterim Report and Accounts
2nd Mar 202210:23 amRNS2019 Redemption Portfolio
2nd Mar 202210:20 amRNSNet Asset Value(s)
23rd Feb 20224:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
21st Feb 202211:21 amRNSHolding(s) in Company
20th Jan 20225:22 pmRNSHolding(s) in Company
6th Jan 20225:06 pmRNS2019 Redemption Portfolio
6th Jan 20224:59 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.